Delivery Order SPE2DB22D3301-SPE2DB25FX7YQ

Award Date 1/3/25
Potential Completion Date 1/6/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,238.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of Calcipotriene 0.005% Cream, a topical medication, with a completion date of September 4, 2024. The contract is a firm-fixed-price delivery order, and there was no set-aside designation. AmerisourceBergen, as a major pharmaceutical distributor, has been awarded numerous federal contracts by various...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a specific pharmaceutical product - Calcipotriene 0.005% Solution 60ML. The contract has a firm fixed price of $1,326.15 and a completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Calcipotriene 0.005% Solution 60mL, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,117.07 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,513.36 firm fixed-price contract is for the delivery of a 60 gram tube of VTAMA 1% cream. The contract has a period of performance through June 3, 2024 and was awarded on May 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
The Defense Logistics Agency awarded a $147,350 firm fixed price delivery order to Amerisourcebergen Drug Corporation for calcipotriene 0.005% solution. Under this order, Amerisourcebergen will deliver 60ml bottles of the calcipotriene topical solution to a location in Conshohocken, Pennsylvania by July 17, 2023 in support of Department of Defense dermatological medication needs. As a top 100 Defense Logistics Agency contractor, Amerisourcebergen regularly supplies pharmaceuticals and medical...
This federal contract award is for $2,036.86 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pimecrolimus 1% Cream, a medical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price, and has an Ultimate Completion Date of August 20, 2024. There was no set-aside designation for this award. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,188.81 firm fixed-price delivery order (SPE2DX15D6028|SPE2DX25FWEFB) is for Dovonex 0.005% 1S, a prescription medication. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Pimecrolimus 1% Cream 30g, a topical medication, and has a ceiling value of $1,539.00. This is a Firm Fixed Price Delivery Order contract with a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The contract, valued at $14,117.31, is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,175.52 Firm Fixed Price delivery order is for Pimecrolimus 1% Cream, a specialty medication, with a completion date of December 12, 2024. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a primary vehicle for...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX7YQ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.73 firm fixed-price delivery order is for the supply of 60 gram tubes of Calcipotriene 0.005% cream. The contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating open competition.

Generated 4/4/25, 10:07 AM